Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03053440
Title A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications

lymphoplasmacytic lymphoma

Therapies

Ibrutinib

Zanubrutinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.